Crossmark

Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines

Crossref DOI link: https://doi.org/10.1007/s10238-024-01527-5

Published Online: 2024-12-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rahdan, Fereshteh

Abedi, Fatemeh

Dianat-Moghadam, Hassan

Sani, Maryam Zamani

Taghizadeh, Mohammad

Alizadeh, Effat
Funding

Funding for this research was provided by:

Tabriz University of Medical Sciences (IR.TBZMED.VCR.REC.1400.476)
License Information

Text and Data Mining valid from 2024-12-02

Version of Record valid from 2024-12-02
More Information

Article History

Received: 9 October 2024

Accepted: 22 November 2024

First Online: 2 December 2024

Declarations

:

: The authors declare no competing interests.

: Not applicable.

Document is current

Any future updates will be listed below